FDA Inspection 776607 — Uniglobe Research Corporation

Uniglobe Research Corporation — FEI 1000124912

The FDA completed an inspection of Uniglobe Research Corporation on April 13, 2012 in Reseda, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 13, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Reseda, CA (United States)

Citations

IDCFRDescription
1503021 CFR 606.60(b)Equipment calibration frequency
15521 CFR 606.160(b)Required records